<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2017-11-22" version="218">
<accession>P07948</accession>
<accession>A0AVQ5</accession>
<name>LYN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase Lyn</fullName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Lck/Yes-related novel protein tyrosine kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>V-yes-1 Yamaguchi sarcoma viral related oncogene homolog</fullName>
</alternativeName>
<alternativeName>
<fullName>p53Lyn</fullName>
</alternativeName>
<alternativeName>
<fullName>p56Lyn</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">LYN</name>
<name type="synonym">JTK8</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Mol. Cell. Biol." volume="7" first="237" last="243">
<title>The yes-related cellular gene lyn encodes a possible tyrosine kinase similar to p56lck.</title>
<authorList>
<person name="Yamanashi Y."/>
<person name="Fukushige S."/>
<person name="Semba K."/>
<person name="Sukegawa J."/>
<person name="Miyajima N."/>
<person name="Matsubara K."/>
<person name="Yamamoto T."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="3561390"/>
<dbReference type="DOI" id="10.1128/MCB.7.1.237"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Gene" volume="138" first="219" last="222">
<title>The cDNAs encoding two forms of the LYN protein tyrosine kinase are expressed in rat mast cells and human myeloid cells.</title>
<authorList>
<person name="Rider L.G."/>
<person name="Raben N."/>
<person name="Miller L."/>
<person name="Jelsema C."/>
</authorList>
<dbReference type="PubMed" id="8125304"/>
<dbReference type="DOI" id="10.1016/0378-1119(94)90811-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="8913" last="8917">
<title>Putative tyrosine kinases expressed in K-562 human leukemia cells.</title>
<authorList>
<person name="Partanen J."/>
<person name="Maekelae T.P."/>
<person name="Alitalo R."/>
<person name="Lehvaeslaiho H."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="2247464"/>
<dbReference type="DOI" id="10.1073/pnas.87.22.8913"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 369-424</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1992" name="Biochem. Biophys. Res. Commun." volume="186" first="1403" last="1409">
<title>Expression of the B cell-associated tyrosine kinase gene Lyn in primary neuroblastoma tumours and its modulation during the differentiation of neuroblastoma cell lines.</title>
<authorList>
<person name="Bielke W."/>
<person name="Ziemiecki A."/>
<person name="Kappos L."/>
<person name="Miescher G.C."/>
</authorList>
<dbReference type="PubMed" id="1510669"/>
<dbReference type="DOI" id="10.1016/S0006-291X(05)81562-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 369-424</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="194" first="222" last="225">
<title>CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.</title>
<authorList>
<person name="Roifman C.M."/>
<person name="Ke S."/>
</authorList>
<dbReference type="PubMed" id="7687428"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1807"/>
</citation>
<scope>FUNCTION IN CD19 PHOSPHORYLATION</scope>
<scope>INTERACTION WITH CD19</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="3631" last="3635">
<title>Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling.</title>
<authorList>
<person name="Yamanashi Y."/>
<person name="Okada M."/>
<person name="Semba T."/>
<person name="Yamori T."/>
<person name="Umemori H."/>
<person name="Tsunasawa S."/>
<person name="Toyoshima K."/>
<person name="Kitamura D."/>
<person name="Watanabe T."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="7682714"/>
<dbReference type="DOI" id="10.1073/pnas.90.8.3631"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH HCLS1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Exp. Med." volume="180" first="1165" last="1170">
<title>Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn.</title>
<authorList>
<person name="Wang A.V."/>
<person name="Scholl P.R."/>
<person name="Geha R.S."/>
</authorList>
<dbReference type="PubMed" id="8064233"/>
<dbReference type="DOI" id="10.1084/jem.180.3.1165"/>
</citation>
<scope>INTERACTION WITH FCGR1A</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="Mol. Cell. Biol." volume="14" first="7306" last="7313">
<title>Functional analysis of Csk in signal transduction through the B-cell antigen receptor.</title>
<authorList>
<person name="Hata A."/>
<person name="Sabe H."/>
<person name="Kurosaki T."/>
<person name="Takata M."/>
<person name="Hanafusa H."/>
</authorList>
<dbReference type="PubMed" id="7935444"/>
<dbReference type="DOI" id="10.1128/MCB.14.11.7306"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-397 AND TYR-508</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Immunity" volume="2" first="155" last="166">
<title>Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.</title>
<authorList>
<person name="Miller C.L."/>
<person name="Burkhardt A.L."/>
<person name="Lee J.H."/>
<person name="Stealey B."/>
<person name="Longnecker R."/>
<person name="Bolen J.B."/>
<person name="Kieff E."/>
</authorList>
<dbReference type="PubMed" id="7895172"/>
<dbReference type="DOI" id="10.1016/S1074-7613(95)80040-9"/>
</citation>
<scope>INTERACTION WITH EPSTEIN-BARR VIRUS LMP2A</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="2342" last="2351">
<title>Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.</title>
<authorList>
<person name="Hirao A."/>
<person name="Hamaguchi I."/>
<person name="Suda T."/>
<person name="Yamaguchi N."/>
</authorList>
<dbReference type="PubMed" id="9171348"/>
<dbReference type="DOI" id="10.1093/emboj/16.9.2342"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-508 BY MATK</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Immunol. Lett." volume="57" first="159" last="164">
<title>Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.</title>
<authorList>
<person name="Sarmay G."/>
<person name="Koncz G."/>
<person name="Pecht I."/>
<person name="Gergely J."/>
</authorList>
<dbReference type="PubMed" id="9232445"/>
<dbReference type="DOI" id="10.1016/S0165-2478(97)00055-2"/>
</citation>
<scope>INTERACTION WITH FCGR2B</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27450" last="27455">
<title>Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells.</title>
<authorList>
<person name="Linnekin D."/>
<person name="DeBerry C.S."/>
<person name="Mou S."/>
</authorList>
<dbReference type="PubMed" id="9341198"/>
<dbReference type="DOI" id="10.1074/jbc.272.43.27450"/>
</citation>
<scope>INTERACTION WITH KIT</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="34663" last="34668">
<title>Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="10574931"/>
<dbReference type="DOI" id="10.1074/jbc.274.49.34663"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE; APOPTOSIS AND PHOSPHORYLATION OF PTPN6/SHPTP1</scope>
<scope>INTERACTION WITH PTPN6/SHPTP1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="3365" last="3375">
<title>cbl-3: a new mammalian cbl family protein.</title>
<authorList>
<person name="Keane M.M."/>
<person name="Ettenberg S.A."/>
<person name="Nau M.M."/>
<person name="Banerjee P."/>
<person name="Cuello M."/>
<person name="Penninger J."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="10362357"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202753"/>
</citation>
<scope>INTERACTION WITH CBLC</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="16174" last="16182">
<title>Substrate recognition by the Lyn protein-tyrosine kinase. NMR structure of the immunoreceptor tyrosine-based activation motif signaling region of the B cell antigen receptor.</title>
<authorList>
<person name="Gaul B.S."/>
<person name="Harrison M.L."/>
<person name="Geahlen R.L."/>
<person name="Burton R.A."/>
<person name="Post C.B."/>
</authorList>
<dbReference type="PubMed" id="10748115"/>
<dbReference type="DOI" id="10.1074/jbc.M909044199"/>
</citation>
<scope>FUNCTION IN CD79A PHOSPHORYLATION</scope>
<scope>INTERACTION WITH CD79A</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Blood" volume="98" first="343" last="350">
<title>Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.</title>
<authorList>
<person name="O'Laughlin-Bunner B."/>
<person name="Radosevic N."/>
<person name="Taylor M.L."/>
<person name="Shivakrupa R."/>
<person name="DeBerry C."/>
<person name="Metcalfe D.D."/>
<person name="Zhou M."/>
<person name="Lowell C."/>
<person name="Linnekin D."/>
</authorList>
<dbReference type="PubMed" id="11435302"/>
<dbReference type="DOI" id="10.1182/blood.V98.2.343"/>
</citation>
<scope>FUNCTION IN REGULATION OF MAST CELL PROLIFERATION</scope>
<scope>MUTAGENESIS OF LYS-275</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Mol. Pharmacol." volume="59" first="996" last="1011">
<title>Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic AMP-specific phosphodiesterase PDE4A10.</title>
<authorList>
<person name="Rena G."/>
<person name="Begg F."/>
<person name="Ross A."/>
<person name="MacKenzie C."/>
<person name="McPhee I."/>
<person name="Campbell L."/>
<person name="Huston E."/>
<person name="Sullivan M."/>
<person name="Houslay M.D."/>
</authorList>
<dbReference type="PubMed" id="11306681"/>
</citation>
<scope>INTERACTION WITH PDE4A</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5370" last="5380">
<title>Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Weichselbaum R."/>
<person name="Kharbanda S."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="10891478"/>
<dbReference type="DOI" id="10.1128/MCB.20.15.5370-5380.2000"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="10172" last="10177">
<title>Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis.</title>
<authorList>
<person name="Grishin A.V."/>
<person name="Azhipa O."/>
<person name="Semenov I."/>
<person name="Corey S.J."/>
</authorList>
<dbReference type="PubMed" id="11517336"/>
<dbReference type="DOI" id="10.1073/pnas.191130798"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE; APOPTOSIS AND PHOSPHORYLATION OF PPP1R15A</scope>
<scope>INTERACTION WITH PPP1R15A</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-275</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="13732" last="13738">
<title>Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.</title>
<authorList>
<person name="Liang X."/>
<person name="Wisniewski D."/>
<person name="Strife A."/>
<person name="Shivakrupa R."/>
<person name="Clarkson B."/>
<person name="Resh M.D."/>
</authorList>
<dbReference type="PubMed" id="11825908"/>
<dbReference type="DOI" id="10.1074/jbc.M200277200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF KIT AND DOK1</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH KIT</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Cancer Biol. Ther." volume="2" first="187" last="193">
<title>DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.</title>
<authorList>
<person name="Li Y."/>
<person name="Chen W."/>
<person name="Ren J."/>
<person name="Yu W.H."/>
<person name="Li Q."/>
<person name="Yoshida K."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12750561"/>
<dbReference type="DOI" id="10.4161/cbt.2.2.282"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="8837" last="8845">
<title>Identification of UNC119 as a novel activator of SRC-type tyrosine kinases.</title>
<authorList>
<person name="Cen O."/>
<person name="Gorska M.M."/>
<person name="Stafford S.J."/>
<person name="Sur S."/>
<person name="Alam R."/>
</authorList>
<dbReference type="PubMed" id="12496276"/>
<dbReference type="DOI" id="10.1074/jbc.M208261200"/>
</citation>
<scope>INTERACTION WITH UNC119</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Blood" volume="103" first="3736" last="3743">
<title>Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.</title>
<authorList>
<person name="Lannutti B.J."/>
<person name="Drachman J.G."/>
</authorList>
<dbReference type="PubMed" id="14726379"/>
<dbReference type="DOI" id="10.1182/blood-2003-10-3566"/>
</citation>
<scope>FUNCTION IN THPO-MEDIATED CELL PROLIFERATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="165" first="641" last="652">
<title>Trafficking of Lyn through the Golgi caveolin involves the charged residues on alphaE and alphaI helices in the kinase domain.</title>
<authorList>
<person name="Kasahara K."/>
<person name="Nakayama Y."/>
<person name="Ikeda K."/>
<person name="Fukushima Y."/>
<person name="Matsuda D."/>
<person name="Horimoto S."/>
<person name="Yamaguchi N."/>
</authorList>
<dbReference type="PubMed" id="15173188"/>
<dbReference type="DOI" id="10.1083/jcb.200403011"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF LYS-275; ASP-346; GLU-353; ASP-498 AND ASP-499</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="337" first="1" last="13">
<title>Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.</title>
<authorList>
<person name="Roskoski R. Jr."/>
</authorList>
<dbReference type="PubMed" id="16129412"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.055"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="21029" last="21035">
<title>Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein.</title>
<authorList>
<person name="Brunati A.M."/>
<person name="Deana R."/>
<person name="Folda A."/>
<person name="Massimino M.L."/>
<person name="Marin O."/>
<person name="Ledro S."/>
<person name="Pinna L.A."/>
<person name="Donella-Deana A."/>
</authorList>
<dbReference type="PubMed" id="15795233"/>
<dbReference type="DOI" id="10.1074/jbc.M412634200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HCLS1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-508</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Blood" volume="107" first="4234" last="4239">
<title>Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells.</title>
<authorList>
<person name="Nakata Y."/>
<person name="Tomkowicz B."/>
<person name="Gewirtz A.M."/>
<person name="Ptasznik A."/>
</authorList>
<dbReference type="PubMed" id="16467205"/>
<dbReference type="DOI" id="10.1182/blood-2005-08-3343"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="30907" last="30916">
<title>Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity.</title>
<authorList>
<person name="Meyn M.A. III"/>
<person name="Wilson M.B."/>
<person name="Abdi F.A."/>
<person name="Fahey N."/>
<person name="Schiavone A.P."/>
<person name="Wu J."/>
<person name="Hochrein J.M."/>
<person name="Engen J.R."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="16912036"/>
<dbReference type="DOI" id="10.1074/jbc.M605902200"/>
</citation>
<scope>INTERACTION WITH ABL1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="31920" last="31929">
<title>Csk-binding protein mediates sequential enzymatic down-regulation and degradation of Lyn in erythropoietin-stimulated cells.</title>
<authorList>
<person name="Ingley E."/>
<person name="Schneider J.R."/>
<person name="Payne C.J."/>
<person name="McCarthy D.J."/>
<person name="Harder K.W."/>
<person name="Hibbs M.L."/>
<person name="Klinken S.P."/>
</authorList>
<dbReference type="PubMed" id="16920712"/>
<dbReference type="DOI" id="10.1074/jbc.M602637200"/>
</citation>
<scope>INTERACTION WITH PAG1</scope>
<scope>MUTAGENESIS OF TYR-397 AND TYR-508</scope>
<scope>ENZYME REGULATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Biochem. J." volume="403" first="275" last="281">
<title>Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets.</title>
<authorList>
<person name="Rathore V.B."/>
<person name="Okada M."/>
<person name="Newman P.J."/>
<person name="Newman D.K."/>
</authorList>
<dbReference type="PubMed" id="17233630"/>
<dbReference type="DOI" id="10.1042/BJ20061618"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="27181" last="27191">
<title>Leupaxin negatively regulates B cell receptor signaling.</title>
<authorList>
<person name="Chew V."/>
<person name="Lam K.P."/>
</authorList>
<dbReference type="PubMed" id="17640867"/>
<dbReference type="DOI" id="10.1074/jbc.M704625200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF LPXN</scope>
<scope>INTERACTION WITH LPXN</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="37669" last="37677">
<title>TOM1L1 is a Lyn substrate involved in FcepsilonRI signaling in mast cells.</title>
<authorList>
<person name="Zhang J."/>
<person name="Suzuki K."/>
<person name="Hitomi T."/>
<person name="Siraganian R.P."/>
</authorList>
<dbReference type="PubMed" id="17977829"/>
<dbReference type="DOI" id="10.1074/jbc.M705168200"/>
</citation>
<scope>INTERACTION WITH TOM1L1</scope>
<scope>FUNCTION IN TOM1L1 PHOSPHORYLATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Blood" volume="111" first="2269" last="2279">
<title>A critical role for Lyn in acute myeloid leukemia.</title>
<authorList>
<person name="Dos Santos C."/>
<person name="Demur C."/>
<person name="Bardet V."/>
<person name="Prade-Houdellier N."/>
<person name="Payrastre B."/>
<person name="Recher C."/>
</authorList>
<dbReference type="PubMed" id="18056483"/>
<dbReference type="DOI" id="10.1182/blood-2007-04-082099"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION AND SURVIVAL</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Blood" volume="111" first="2310" last="2320">
<title>Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts.</title>
<authorList>
<person name="Tauzin S."/>
<person name="Ding H."/>
<person name="Khatib K."/>
<person name="Ahmad I."/>
<person name="Burdevet D."/>
<person name="van Echten-Deckert G."/>
<person name="Lindquist J.A."/>
<person name="Schraven B."/>
<person name="Din N.U."/>
<person name="Borisch B."/>
<person name="Hoessli D.C."/>
</authorList>
<dbReference type="PubMed" id="18070987"/>
<dbReference type="DOI" id="10.1182/blood-2007-05-090985"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT TYR-397 AND TYR-508</scope>
<scope>INTERACTION WITH PAG1 AND STAT3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Blood" volume="111" first="3821" last="3829">
<title>Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.</title>
<authorList>
<person name="Wu J."/>
<person name="Meng F."/>
<person name="Lu H."/>
<person name="Kong L."/>
<person name="Bornmann W."/>
<person name="Peng Z."/>
<person name="Talpaz M."/>
<person name="Donato N.J."/>
</authorList>
<dbReference type="PubMed" id="18235045"/>
<dbReference type="DOI" id="10.1182/blood-2007-08-109330"/>
</citation>
<scope>INTERACTION WITH CBL AND BCR-ABL</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF BCR-ABL</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Exp. Cell Res." volume="314" first="3392" last="3404">
<title>Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity.</title>
<authorList>
<person name="Ikeda K."/>
<person name="Nakayama Y."/>
<person name="Togashi Y."/>
<person name="Obata Y."/>
<person name="Kuga T."/>
<person name="Kasahara K."/>
<person name="Fukumoto Y."/>
<person name="Yamaguchi N."/>
</authorList>
<dbReference type="PubMed" id="18817770"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2008.08.019"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MYRISTOYLATION AT GLY-2</scope>
<scope>PALMITOYLATION AT CYS-3</scope>
<scope>MUTAGENESIS OF GLY-2; CYS-3 AND LYS-275</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="J. Immunol." volume="181" first="4632" last="4637">
<title>Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase.</title>
<authorList>
<person name="Malik M."/>
<person name="Chen Y.-Y."/>
<person name="Kienzle M.F."/>
<person name="Tomkowicz B.E."/>
<person name="Collman R.G."/>
<person name="Ptasznik A."/>
</authorList>
<dbReference type="PubMed" id="18802065"/>
<dbReference type="DOI" id="10.4049/jimmunol.181.7.4632"/>
</citation>
<scope>FUNCTION IN ADHESION AND CELL MIGRATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="J. Natl. Cancer Inst." volume="100" first="926" last="939">
<title>Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.</title>
<authorList>
<person name="Wu J."/>
<person name="Meng F."/>
<person name="Kong L.Y."/>
<person name="Peng Z."/>
<person name="Ying Y."/>
<person name="Bornmann W.G."/>
<person name="Darnay B.G."/>
<person name="Lamothe B."/>
<person name="Sun H."/>
<person name="Talpaz M."/>
<person name="Donato N.J."/>
</authorList>
<dbReference type="PubMed" id="18577747"/>
<dbReference type="DOI" id="10.1093/jnci/djn188"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-193 AND TYR-460</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-13; TYR-473 AND TYR-508</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="BMC Immunol." volume="10" first="53" last="53">
<title>Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.</title>
<authorList>
<person name="Voss M."/>
<person name="Lettau M."/>
<person name="Janssen O."/>
</authorList>
<dbReference type="PubMed" id="19807924"/>
<dbReference type="DOI" id="10.1186/1471-2172-10-53"/>
</citation>
<scope>INTERACTION WITH FASLG</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2009" name="J. Cell. Biochem." volume="108" first="877" last="885">
<title>Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins.</title>
<authorList>
<person name="Kleino I."/>
<person name="Ortiz R.M."/>
<person name="Yritys M."/>
<person name="Huovila A.P."/>
<person name="Saksela K."/>
</authorList>
<dbReference type="PubMed" id="19718658"/>
<dbReference type="DOI" id="10.1002/jcb.22317"/>
</citation>
<scope>INTERACTION WITH ADAM15</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-13; SER-228; TYR-306; TYR-316; TYR-473 AND TYR-508</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="J. Leukoc. Biol." volume="87" first="691" last="701">
<title>The T cell receptor-mediated phosphorylation of Pyk2 tyrosines 402 and 580 occurs via a distinct mechanism than other receptor systems.</title>
<authorList>
<person name="Collins M."/>
<person name="Tremblay M."/>
<person name="Chapman N."/>
<person name="Curtiss M."/>
<person name="Rothman P.B."/>
<person name="Houtman J.C."/>
</authorList>
<dbReference type="PubMed" id="20028775"/>
<dbReference type="DOI" id="10.1189/jlb.0409227"/>
</citation>
<scope>FUNCTION IN PTK2B/PYK2 PHOSPHORYLATION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="155" last="161">
<title>CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.</title>
<authorList>
<person name="Stewart C.R."/>
<person name="Stuart L.M."/>
<person name="Wilkinson K."/>
<person name="van Gils J.M."/>
<person name="Deng J."/>
<person name="Halle A."/>
<person name="Rayner K.J."/>
<person name="Boyer L."/>
<person name="Zhong R."/>
<person name="Frazier W.A."/>
<person name="Lacy-Hulbert A."/>
<person name="El Khoury J."/>
<person name="Golenbock D.T."/>
<person name="Moore K.J."/>
</authorList>
<dbReference type="PubMed" id="20037584"/>
<dbReference type="DOI" id="10.1038/ni.1836"/>
</citation>
<scope>FUNCTION IN LTR4 AND LTR6 HETERODIMERIZATION</scope>
<scope>INTERACTION WITH CD36</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="11429" last="11434">
<title>Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.</title>
<authorList>
<person name="Mund T."/>
<person name="Pelham H.R."/>
</authorList>
<dbReference type="PubMed" id="20534535"/>
<dbReference type="DOI" id="10.1073/pnas.0911714107"/>
</citation>
<scope>INTERACTION WITH NDFIP1 AND NDFIP2</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="4550" last="4562">
<title>SCIMP, a transmembrane adapter protein involved in major histocompatibility complex class II signaling.</title>
<authorList>
<person name="Draber P."/>
<person name="Vonkova I."/>
<person name="Stepanek O."/>
<person name="Hrdinka M."/>
<person name="Kucova M."/>
<person name="Skopcova T."/>
<person name="Otahal P."/>
<person name="Angelisova P."/>
<person name="Horejsi V."/>
<person name="Yeung M."/>
<person name="Weiss A."/>
<person name="Brdicka T."/>
</authorList>
<dbReference type="PubMed" id="21930792"/>
<dbReference type="DOI" id="10.1128/MCB.05817-11"/>
</citation>
<scope>INTERACTION WITH SCIMP</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2004" name="Mol. Immunol." volume="41" first="631" last="643">
<title>Src-family kinases: rheostats of immune cell signaling.</title>
<authorList>
<person name="Lowell C.A."/>
</authorList>
<dbReference type="PubMed" id="15220000"/>
<dbReference type="DOI" id="10.1016/j.molimm.2004.04.010"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="8001" last="8006">
<title>Src-family kinases in B-cell development and signaling.</title>
<authorList>
<person name="Gauld S.B."/>
<person name="Cambier J.C."/>
</authorList>
<dbReference type="PubMed" id="15489917"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208075"/>
</citation>
<scope>REVIEW ON ROLE IN B CELLS</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2005" name="Immunity" volume="22" first="9" last="18">
<title>Lyn tyrosine kinase: accentuating the positive and the negative.</title>
<authorList>
<person name="Xu Y."/>
<person name="Harder K.W."/>
<person name="Huntington N.D."/>
<person name="Hibbs M.L."/>
<person name="Tarlinton D.M."/>
</authorList>
<dbReference type="PubMed" id="15664155"/>
<dbReference type="DOI" id="10.1016/S1074-7613(04)00381-4"/>
</citation>
<scope>REVIEW ON ROLE IN B CELLS</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2006" name="Growth Factors" volume="24" first="137" last="149">
<title>The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling.</title>
<authorList>
<person name="Hibbs M.L."/>
<person name="Harder K.W."/>
</authorList>
<dbReference type="PubMed" id="16801133"/>
<dbReference type="DOI" id="10.1080/08977190600581327"/>
</citation>
<scope>REVIEW ON ROLE IN GROWTH FACTOR SIGNALING</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="Adv. Immunol." volume="98" first="85" last="120">
<title>New insights on mast cell activation via the high affinity receptor for IgE.</title>
<authorList>
<person name="Rivera J."/>
<person name="Fierro N.A."/>
<person name="Olivera A."/>
<person name="Suzuki R."/>
</authorList>
<dbReference type="PubMed" id="18772004"/>
<dbReference type="DOI" id="10.1016/S0065-2776(08)00403-3"/>
</citation>
<scope>REVIEW ON ROLE IN MAST CELLS</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2009" name="Immunol. Rev." volume="228" first="23" last="40">
<title>Multiple roles of Lyn kinase in myeloid cell signaling and function.</title>
<authorList>
<person name="Scapini P."/>
<person name="Pereira S."/>
<person name="Zhang H."/>
<person name="Lowell C.A."/>
</authorList>
<dbReference type="PubMed" id="19290919"/>
<dbReference type="DOI" id="10.1111/j.1600-065X.2008.00758.x"/>
</citation>
<scope>ROLE IN MYELOID CELL FUNCTION</scope>
<scope>SIGNALING</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-13</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-13</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="60">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-13</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="61">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="4919" last="4919">
<title>Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.</title>
<authorList>
<person name="Thinon E."/>
<person name="Serwa R.A."/>
<person name="Broncel M."/>
<person name="Brannigan J.A."/>
<person name="Brassat U."/>
<person name="Wright M.H."/>
<person name="Heal W.P."/>
<person name="Wilkinson A.J."/>
<person name="Mann D.J."/>
<person name="Tate E.W."/>
</authorList>
<dbReference type="PubMed" id="25255805"/>
<dbReference type="DOI" id="10.1038/ncomms5919"/>
</citation>
<scope>MYRISTOYLATION AT GLY-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="5120" last="5130">
<title>Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck.</title>
<authorList>
<person name="Schweimer K."/>
<person name="Hoffmann S."/>
<person name="Bauer F."/>
<person name="Friedrich U."/>
<person name="Kardinal C."/>
<person name="Feller S.M."/>
<person name="Biesinger B."/>
<person name="Sticht H."/>
</authorList>
<dbReference type="PubMed" id="11955060"/>
<dbReference type="DOI" id="10.1021/bi015986j"/>
</citation>
<scope>STRUCTURE BY NMR OF 61-123 IN COMPLEX WITH SAIMIRIINE HERPESVIRUS 2 TYROSINE KINASE INTERACTING PROTEIN</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2005" name="Protein Sci." volume="14" first="2487" last="2498">
<title>Structural characterization of Lyn-SH3 domain in complex with a herpesviral protein reveals an extended recognition motif that enhances binding affinity.</title>
<authorList>
<person name="Bauer F."/>
<person name="Schweimer K."/>
<person name="Meiselbach H."/>
<person name="Hoffmann S."/>
<person name="Rosch P."/>
<person name="Sticht H."/>
</authorList>
<dbReference type="PubMed" id="16155203"/>
<dbReference type="DOI" id="10.1110/ps.051563605"/>
</citation>
<scope>STRUCTURE BY NMR OF 61-122</scope>
<scope>INTERACTION WITH HERPESVIRUS TYROSINE KINASE INTERACTING PROTEIN</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="6557" last="6560">
<title>Structural basis for the inhibitor recognition of human Lyn kinase domain.</title>
<authorList>
<person name="Miyano N."/>
<person name="Kinoshita T."/>
<person name="Nakai R."/>
<person name="Kirii Y."/>
<person name="Yokota K."/>
<person name="Tada T."/>
</authorList>
<dbReference type="PubMed" id="19857964"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.10.038"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 233-512 IN COMPLEX WITH STAUROSPORINE</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] TYR-385</scope>
</reference>
<comment type="function">
<text evidence="16 17 18 20 21 22 26 28 30 35 36 37 38 39 40 41 43 47 48 54">Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, PTK2B/PYK2, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr-72'. Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation.</text>
</comment>
<comment type="catalytic activity">
<text evidence="14 21 22 53 57">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="32 56">Subject to autoinhibition, mediated by intramolecular interactions between the SH2 domain and the C-terminal phosphotyrosine. Phosphorylation at Tyr-397 is required for optimal activity. Phosphorylated by CSK at Tyr-508; phosphorylation at Tyr-508 inhibits kinase activity. Kinase activity is modulated by dephosphorylation by PTPRC/CD45. Inhibited by Dasatinib, PP2, and SU6656.</text>
</comment>
<comment type="subunit">
<text evidence="10 15 16 17 19 21 22 23 24 25 29 31 32 33 35 36 38 39 44 45 46 48 49 50 53 54 55 57 59 60">Interacts with TEC. Interacts (via SH2 domain) with FLT3 (tyrosine phosphorylated). Interacts with LIME1 and with CD79A upon activation of the B-cell antigen receptor. Interacts with the B-cell receptor complex. Interacts with phosphorylated THEMIS2. Interacts with EPOR. Interacts with MS4A2/FCER1B. Interaction (via the SH2 and SH3 domains) with MUC1 is stimulated by IL7 and the subsequent phosphorylation increases the binding between MUC1 and CTNNB1/beta-catenin. Interacts with ADAM15. Interacts with NDFIP2 and more weakly with NDFIP1. Interacts with FASLG. Interacts with KIT. Interacts with HCLS1. Interacts with FCGR2B. Interacts with FCGR1A; the interaction may be indirect. Interacts with CD19, CD22, CD79A and CD79B. Interacts (via SH3 domain) with CBLC, PPP1R15A and PDE4A. Interacts with TGFB1I1. Interacts (via SH3 domain) with PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase; this interaction enhances phosphatidylinositol 3-kinase activity. Interacts with CSF2RB, the common subunit of the IL3, IL5 and CSF2 receptors. Interacts with PAG1; identified in a complex with PAG1 and STAT3. Interacts with ABL1. Interacts with PTPN6/SHP-1. Interacts (via SH3 domain) with SCIMP (via proline-rich region). Interacts with LPXN (via LD motif 3) and the interaction is induced upon B-cell antigen receptor (BCR) activation. Interacts (via SH3-domain) with ANKRD54 (via ankyrin repeat region) in an activation-independent status of LYN. Forms a multiprotein complex with ANKRD54 and HCLS1. Interacts with Epstein-Barr virus LMP2A. Interacts with Herpes virus saimiri tyrosine kinase interacting protein (Tip). Interacts (via SH2 and SH3 domains) with UNC119; leading to LYN activation. Interacts with CD36. Interacts with LYN (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-710506">
<id>O92972</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-866709">
<id>P22575</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-706378">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-710918">
<id>Q9WMX2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-621463">
<id>Q8R5G7</id>
<label>Arap3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-78277">
<id>P20273</id>
<label>CD22</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-6267018">
<id>P25063</id>
<label>CD24</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-2808214">
<id>P16671</id>
<label>CD36</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-8346984">
<id>Q08857</id>
<label>Cd36</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-6139068">
<id>P11049</id>
<label>CD37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-519280">
<id>P46527</id>
<label>CDKN1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-515278">
<id>Q9HCN6</id>
<label>GP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-15816577">
<id>Q9HCN6-1</id>
<label>GP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-703066">
<id>P05556</id>
<label>ITGB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6895930"/>
<interactant intactId="EBI-355924">
<id>P33993</id>
<label>MCM7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-2828115">
<id>Q9NWQ8</id>
<label>PAG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-296739">
<id>P63244</id>
<label>RACK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79452"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="62">Membrane</location>
<topology evidence="62">Lipid-anchor</topology>
</subcellularLocation>
<text>Accumulates in the nucleus by inhibition of CRM1-mediated nuclear export. Nuclear accumulation is increased by inhibition of its kinase activity. The trafficking from the Golgi apparatus to the plasma membrane occurs in a kinase domain-dependent but kinase activity independent manner and is mediated by exocytic vesicular transport. Detected on plasma membrane lipid rafts.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P07948-1</id>
<name>1</name>
<name>LYN A</name>
<name>p56lyn</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P07948-2</id>
<name>2</name>
<name>LYN B</name>
<name>p53lyn</name>
<sequence type="described" ref="VSP_005002"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="52 57">Detected in monocytes (at protein level). Detected in placenta, and in fetal brain, lung, liver and kidney. Widely expressed in a variety of organs, tissues, and cell types such as epidermoid, hematopoietic, and neuronal cells. Expressed in primary neuroblastoma tumors.</text>
</comment>
<comment type="domain">
<text evidence="27">The protein kinase domain plays an important role in its localization in the cell membrane.</text>
</comment>
<comment type="PTM">
<text evidence="32 49">Ubiquitinated by CBL, leading to its degradation. Ubiquitination is SH3-dependent.</text>
</comment>
<comment type="PTM">
<text evidence="37 38 40 56 57 58 60">Autophosphorylated. Phosphorylated on tyrosine residues in response to KIT signaling. Phosphorylation at Tyr-397 is required for optimal activity. Phosphorylation at Tyr-508 inhibits kinase activity. Phosphorylated at Tyr-508 by CSK. Dephosphorylated by PTPRC/CD45. Becomes rapidly phosphorylated upon activation of the B-cell receptor and the immunoglobulin receptor FCGR1A.</text>
</comment>
<comment type="disease">
<text>Constitutively phosphorylated and activated in cells from a number of chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) patients. Mediates phosphorylation of the BCR-ABL fusion protein. Abnormally elevated expression levels or activation of LYN signaling may play a role in survival and proliferation of some types of cancer cells.</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="M16038">
<property type="protein sequence ID" value="AAA59540.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M79321">
<property type="protein sequence ID" value="AAB50019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC075001">
<property type="protein sequence ID" value="AAH75001.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC075002">
<property type="protein sequence ID" value="AAH75002.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126456">
<property type="protein sequence ID" value="AAI26457.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126458">
<property type="protein sequence ID" value="AAI26459.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47859.1">
<molecule id="P07948-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6162.1">
<molecule id="P07948-1"/>
</dbReference>
<dbReference type="PIR" id="A26719">
<property type="entry name" value="TVHULY"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001104567.1">
<molecule id="P07948-2"/>
<property type="nucleotide sequence ID" value="NM_001111097.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002341.1">
<molecule id="P07948-1"/>
<property type="nucleotide sequence ID" value="NM_002350.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016868905.1">
<molecule id="P07948-2"/>
<property type="nucleotide sequence ID" value="XM_017013416.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.491767"/>
<dbReference type="UniGene" id="Hs.545418"/>
<dbReference type="PDB" id="1W1F">
<property type="method" value="NMR"/>
<property type="chains" value="A=61-123"/>
</dbReference>
<dbReference type="PDB" id="1WA7">
<property type="method" value="NMR"/>
<property type="chains" value="A=61-123"/>
</dbReference>
<dbReference type="PDB" id="3A4O">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="X=233-512"/>
</dbReference>
<dbReference type="PDB" id="5XY1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=239-512"/>
</dbReference>
<dbReference type="PDBsum" id="1W1F"/>
<dbReference type="PDBsum" id="1WA7"/>
<dbReference type="PDBsum" id="3A4O"/>
<dbReference type="PDBsum" id="5XY1"/>
<dbReference type="ProteinModelPortal" id="P07948"/>
<dbReference type="SMR" id="P07948"/>
<dbReference type="BioGrid" id="110245">
<property type="interactions" value="193"/>
</dbReference>
<dbReference type="CORUM" id="P07948"/>
<dbReference type="DIP" id="DIP-1056N"/>
<dbReference type="ELM" id="P07948"/>
<dbReference type="IntAct" id="P07948">
<property type="interactions" value="72"/>
</dbReference>
<dbReference type="MINT" id="MINT-200655"/>
<dbReference type="STRING" id="9606.ENSP00000428924"/>
<dbReference type="BindingDB" id="P07948"/>
<dbReference type="ChEMBL" id="CHEMBL3905"/>
<dbReference type="DrugBank" id="DB06616">
<property type="generic name" value="Bosutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09079">
<property type="generic name" value="Nintedanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2060"/>
<dbReference type="iPTMnet" id="P07948"/>
<dbReference type="PhosphoSitePlus" id="P07948"/>
<dbReference type="SwissPalm" id="P07948"/>
<dbReference type="BioMuta" id="LYN"/>
<dbReference type="DMDM" id="125480"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P07948"/>
<dbReference type="EPD" id="P07948"/>
<dbReference type="MaxQB" id="P07948"/>
<dbReference type="PaxDb" id="P07948"/>
<dbReference type="PeptideAtlas" id="P07948"/>
<dbReference type="PRIDE" id="P07948"/>
<dbReference type="DNASU" id="4067"/>
<dbReference type="Ensembl" id="ENST00000519728">
<molecule id="P07948-1"/>
<property type="protein sequence ID" value="ENSP00000428924"/>
<property type="gene ID" value="ENSG00000254087"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000520220">
<molecule id="P07948-2"/>
<property type="protein sequence ID" value="ENSP00000428424"/>
<property type="gene ID" value="ENSG00000254087"/>
</dbReference>
<dbReference type="GeneID" id="4067"/>
<dbReference type="KEGG" id="hsa:4067"/>
<dbReference type="UCSC" id="uc003xsk.5">
<molecule id="P07948-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4067"/>
<dbReference type="DisGeNET" id="4067"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000254087.7"/>
<dbReference type="GeneCards" id="LYN"/>
<dbReference type="HGNC" id="HGNC:6735">
<property type="gene designation" value="LYN"/>
</dbReference>
<dbReference type="HPA" id="CAB004492"/>
<dbReference type="HPA" id="HPA001231"/>
<dbReference type="MIM" id="165120">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P07948"/>
<dbReference type="OpenTargets" id="ENSG00000254087"/>
<dbReference type="PharmGKB" id="PA30498"/>
<dbReference type="eggNOG" id="KOG0197">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118938"/>
<dbReference type="HOGENOM" id="HOG000233858"/>
<dbReference type="HOVERGEN" id="HBG008761"/>
<dbReference type="InParanoid" id="P07948"/>
<dbReference type="KO" id="K05854"/>
<dbReference type="OMA" id="WMAYYNN"/>
<dbReference type="OrthoDB" id="EOG091G0D46"/>
<dbReference type="PhylomeDB" id="P07948"/>
<dbReference type="TreeFam" id="TF351634"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433559">
<property type="pathway name" value="Regulation of KIT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202733">
<property type="pathway name" value="Cell surface interactions at the vascular wall"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029481">
<property type="pathway name" value="FCGR activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210990">
<property type="pathway name" value="PECAM1 interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2454202">
<property type="pathway name" value="Fc epsilon receptor (FCERI) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2682334">
<property type="pathway name" value="EPH-Ephrin signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2730905">
<property type="pathway name" value="Role of LAT2/NTAL/LAB on calcium mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871796">
<property type="pathway name" value="FCERI mediated MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871809">
<property type="pathway name" value="FCERI mediated Ca+2 mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389356">
<property type="pathway name" value="CD28 co-stimulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389513">
<property type="pathway name" value="CTLA4 inhibitory signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928662">
<property type="pathway name" value="EPHB-mediated forward signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928663">
<property type="pathway name" value="EPHA-mediated growth cone collapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928665">
<property type="pathway name" value="EPH-ephrin mediated repulsion of cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621480">
<property type="pathway name" value="Dectin-2 family"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5690714">
<property type="pathway name" value="CD22 mediated BCR regulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75892">
<property type="pathway name" value="Platelet Adhesion to exposed collagen"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912631">
<property type="pathway name" value="Regulation of signaling by CBL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="P07948"/>
<dbReference type="SIGNOR" id="P07948"/>
<dbReference type="ChiTaRS" id="LYN">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P07948"/>
<dbReference type="GeneWiki" id="LYN"/>
<dbReference type="GenomeRNAi" id="4067"/>
<dbReference type="PMAP-CutDB" id="P07948"/>
<dbReference type="PRO" id="PR:P07948"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000254087"/>
<dbReference type="CleanEx" id="HS_LYN"/>
<dbReference type="ExpressionAtlas" id="P07948">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P07948">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005913">
<property type="term" value="C:cell-cell adherens junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034666">
<property type="term" value="C:integrin alpha2-beta1 complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042629">
<property type="term" value="C:mast cell granule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030061">
<property type="term" value="C:mitochondrial crista"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005758">
<property type="term" value="C:mitochondrial intermembrane space"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046875">
<property type="term" value="F:ephrin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043015">
<property type="term" value="F:gamma-tubulin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043208">
<property type="term" value="F:glycosphingolipid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051219">
<property type="term" value="F:phosphoprotein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0140031">
<property type="term" value="F:phosphorylation-dependent protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005161">
<property type="term" value="F:platelet-derived growth factor receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004716">
<property type="term" value="F:signal transducer, downstream of receptor, with protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001782">
<property type="term" value="P:B cell homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031668">
<property type="term" value="P:cellular response to extracellular stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034605">
<property type="term" value="P:cellular response to heat"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071300">
<property type="term" value="P:cellular response to retinoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007417">
<property type="term" value="P:central nervous system development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050663">
<property type="term" value="P:cytokine secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097028">
<property type="term" value="P:dendritic cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030218">
<property type="term" value="P:erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002774">
<property type="term" value="P:Fc receptor mediated inhibitory signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002431">
<property type="term" value="P:Fc receptor mediated stimulatory signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002553">
<property type="term" value="P:histamine secretion by mast cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002768">
<property type="term" value="P:immune response-regulating cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060397">
<property type="term" value="P:JAK-STAT cascade involved in growth hormone signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050777">
<property type="term" value="P:negative regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902532">
<property type="term" value="P:negative regulation of intracellular signal transduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070667">
<property type="term" value="P:negative regulation of mast cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002762">
<property type="term" value="P:negative regulation of myeloid leukocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001933">
<property type="term" value="P:negative regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034136">
<property type="term" value="P:negative regulation of toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034144">
<property type="term" value="P:negative regulation of toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031175">
<property type="term" value="P:neuron projection development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014003">
<property type="term" value="P:oligodendrocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902961">
<property type="term" value="P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050861">
<property type="term" value="P:positive regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051272">
<property type="term" value="P:positive regulation of cellular component movement"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000670">
<property type="term" value="P:positive regulation of dendritic cell apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060369">
<property type="term" value="P:positive regulation of Fc receptor mediated stimulatory signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060252">
<property type="term" value="P:positive regulation of glial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070668">
<property type="term" value="P:positive regulation of mast cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070447">
<property type="term" value="P:positive regulation of oligodendrocyte progenitor proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070304">
<property type="term" value="P:positive regulation of stress-activated protein kinase signaling cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002902">
<property type="term" value="P:regulation of B cell apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050855">
<property type="term" value="P:regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033628">
<property type="term" value="P:regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001817">
<property type="term" value="P:regulation of cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050707">
<property type="term" value="P:regulation of cytokine secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045646">
<property type="term" value="P:regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033003">
<property type="term" value="P:regulation of mast cell activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043304">
<property type="term" value="P:regulation of mast cell degranulation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090025">
<property type="term" value="P:regulation of monocyte chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090330">
<property type="term" value="P:regulation of platelet aggregation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001932">
<property type="term" value="P:regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051279">
<property type="term" value="P:regulation of release of sequestered calcium ion into cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043200">
<property type="term" value="P:response to amino acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048678">
<property type="term" value="P:response to axon injury"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009743">
<property type="term" value="P:response to carbohydrate"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009725">
<property type="term" value="P:response to hormone"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014070">
<property type="term" value="P:response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006991">
<property type="term" value="P:response to sterol depletion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009636">
<property type="term" value="P:response to toxic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002513">
<property type="term" value="P:tolerance induction to self antigen"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd10364">
<property type="entry name" value="SH2_Src_Lyn"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd12004">
<property type="entry name" value="SH3_Lyn"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035852">
<property type="entry name" value="Lyn_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR035748">
<property type="entry name" value="Lyn_SH3"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00018">
<property type="entry name" value="SH3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00452">
<property type="entry name" value="SH3DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0519">Myristate</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="51">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Tyrosine-protein kinase Lyn" id="PRO_0000088129">
<location>
<begin position="2"/>
<end position="512"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="13">
<location>
<begin position="63"/>
<end position="123"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="12">
<location>
<begin position="129"/>
<end position="226"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="11">
<location>
<begin position="247"/>
<end position="501"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="11">
<location>
<begin position="253"/>
<end position="261"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="11 14">
<location>
<position position="367"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="11">
<location>
<position position="275"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 7 8 9">
<location>
<position position="11"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 7 8 9">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="40">
<location>
<position position="193"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="306"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="316"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="38 56">
<location>
<position position="397"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="40">
<location>
<position position="460"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4 5">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis, CSK and MATK" evidence="3 4 5 38 56 58">
<location>
<position position="508"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="N-myristoyl glycine" evidence="51 63">
<location>
<position position="2"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="63">
<location>
<position position="3"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005002" evidence="61">
<location>
<begin position="23"/>
<end position="43"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast pleomorphic lobular carcinoma sample; somatic mutation." id="VAR_041737" evidence="34">
<original>D</original>
<variation>Y</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of localization to the cell membrane; when associated with A-3." evidence="42">
<original>G</original>
<variation>A</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of localization to the cell membrane; when associated with A-2." evidence="42">
<original>C</original>
<variation>A</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus; when associated with A-2 and A-3." evidence="20 21 27 42">
<original>K</original>
<variation>A</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="20 21 27 42">
<original>K</original>
<variation>L</variation>
<variation>R</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-353; A-498 and A-499." evidence="27">
<original>D</original>
<variation>A</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-498 and A-499." evidence="27">
<original>E</original>
<variation>A</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced kinase activity." evidence="32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-353 and A-499." evidence="27">
<original>D</original>
<variation>A</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impedes the trafficking from the Golgi apparatus toward the cell membrane; when associated with A-346; A-353 and A-498." evidence="27">
<original>D</original>
<variation>A</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoinhibition and thereby increases kinase activity." evidence="32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="89"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="97"/>
<end position="104"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="110"/>
<end position="114"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="115"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="118"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="259"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="265"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="273"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="290"/>
<end position="293"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="294"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="306"/>
<end position="309"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="316"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="327"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="334"/>
<end position="338"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="341"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="372"/>
<end position="375"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="407"/>
<end position="409"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="412"/>
<end position="416"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="422"/>
<end position="437"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="449"/>
<end position="451"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="452"/>
<end position="457"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="466"/>
<end position="468"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="470"/>
<end position="477"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="478"/>
<end position="480"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="484"/>
<end position="486"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="490"/>
<end position="502"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1W1F"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A4O"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P25911"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10362357"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10574931"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10748115"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10891478"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11306681"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11435302"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11517336"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11825908"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11955060"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12496276"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750561"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14726379"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15173188"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15795233"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16155203"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16467205"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16912036"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16920712"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17233630"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17640867"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17977829"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056483"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18070987"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18235045"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18577747"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18802065"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18817770"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19290919"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19718658"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19807924"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19857964"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20028775"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20037584"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20534535"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21930792"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25255805"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3561390"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7682714"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7687428"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7895172"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7935444"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8064233"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9171348"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9232445"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9341198"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8125304"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000305"/>
<evidence key="63" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18817770"/>
</source>
</evidence>
<sequence length="512" mass="58574" checksum="408D3D461204E378" modified="2007-01-23" version="3">
MGCIKSKGKDSLSDDGVDLKTQPVRNTERTIYVRDPTSNKQQRPVPESQLLPGQRFQTKD
PEEQGDIVVALYPYDGIHPDDLSFKKGEKMKVLEEHGEWWKAKSLLTKKEGFIPSNYVAK
LNTLETEEWFFKDITRKDAERQLLAPGNSAGAFLIRESETLKGSFSLSVRDFDPVHGDVI
KHYKIRSLDNGGYYISPRITFPCISDMIKHYQKQADGLCRRLEKACISPKPQKPWDKDAW
EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD
KLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER
KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF
TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCW
KEKAEERPTFDYLQSVLDDFYTATEGQYQQQP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>